ES2157219T3 - Procedimiento de produccion de una vacuna antitetanica. - Google Patents

Procedimiento de produccion de una vacuna antitetanica.

Info

Publication number
ES2157219T3
ES2157219T3 ES93910244T ES93910244T ES2157219T3 ES 2157219 T3 ES2157219 T3 ES 2157219T3 ES 93910244 T ES93910244 T ES 93910244T ES 93910244 T ES93910244 T ES 93910244T ES 2157219 T3 ES2157219 T3 ES 2157219T3
Authority
ES
Spain
Prior art keywords
pct
antitethane
vaccine
procedure
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93910244T
Other languages
English (en)
Other versions
ES2157219T5 (es
Inventor
Anthony James Sheppard
Peter Anthony Knight
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seqirus Vaccines Ltd
Original Assignee
Evans Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10719649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2157219(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evans Vaccines Ltd filed Critical Evans Vaccines Ltd
Publication of ES2157219T3 publication Critical patent/ES2157219T3/es
Application granted granted Critical
Publication of ES2157219T5 publication Critical patent/ES2157219T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN PROCESO PARA LA PREPARACION DE UN TOXOIDE CONTRA EL TETANO CUYO PROCESO CONSISTE EN INCUBAR UNA TOXINA DEL TETANO PURIFICADA CON DE UN 0,2 A UN 1% (V/V) DE FORMALDEHIDO EN PRESENCIA DE ENTRE 0,005 Y 0,25 M DE LISINA DURANTE DE 24 A 32 DIAS A UN PH DE 6,0 A 8,0 A UNA TEMPERATURA ENTRE 30 Y 45 (GRADOS) C.
ES93910244T 1992-07-31 1993-05-20 Procedimiento de produccion de una vacuna antitetanica. Expired - Lifetime ES2157219T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9216351 1992-07-31
GB929216351A GB9216351D0 (en) 1992-07-31 1992-07-31 Vaccine production

Publications (2)

Publication Number Publication Date
ES2157219T3 true ES2157219T3 (es) 2001-08-16
ES2157219T5 ES2157219T5 (es) 2010-10-26

Family

ID=10719649

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93910244T Expired - Lifetime ES2157219T5 (es) 1992-07-31 1993-05-20 Procedimiento de produccion de una vacuna antitetanica.

Country Status (14)

Country Link
US (1) US6060067A (es)
EP (1) EP0652771B2 (es)
JP (1) JP3901212B2 (es)
AT (1) ATE199059T1 (es)
AU (1) AU690518B2 (es)
CA (1) CA2141410C (es)
DE (1) DE69329922T3 (es)
DK (1) DK0652771T4 (es)
ES (1) ES2157219T5 (es)
GB (1) GB9216351D0 (es)
GR (1) GR3035683T3 (es)
NZ (1) NZ252253A (es)
PT (1) PT652771E (es)
WO (1) WO1994003206A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408094A (pt) * 2003-03-13 2006-02-14 Glaxosmithkline Biolog Sa processo para purificação de uma citolisina bacteriana, citolisina bacteriana, conjugado de polissacarìdeo capsular-pneumolisina bacteriano, composição imunogênica, vacina, processo de produção da vacina, método de tratamento ou prevenção de infecção por streptococcus pneumoniae, e, uso da pneumolisina ou do conjugado de polissacarìdeo-pneumolisina bacteriano
CN1641034B (zh) * 2004-01-14 2010-04-28 中国药品生物制品检定所 破伤风毒素重组抗原制备方法及其应用
AU2008263591C1 (en) * 2007-06-14 2013-09-26 The Secretary Of State For Health Chemically modified peptides with improved immunogenicity
GB2456549A (en) * 2008-01-18 2009-07-22 Health Prot Agency Modified botulinum neurotoxin serotype E (BoNT/E) peptides
EP2906239A1 (en) 2012-10-12 2015-08-19 GlaxoSmithKline Biologicals SA Non-cross-linked acellular pertussis antigens for use in combination vaccines
KR102388325B1 (ko) * 2016-10-20 2022-04-18 케이엠 바이올로직스 가부시키가이샤 저분자화 PRP를 사용한 Hib 컨쥬게이트 백신의 제조방법
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition
CN115448981A (zh) * 2022-10-20 2022-12-09 北京智飞绿竹生物制药有限公司 一种吸附破伤风疫苗的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB969772A (en) * 1961-01-05 1964-09-16 Wellcome Found Toxoids and their production
JP2706792B2 (ja) * 1988-11-29 1998-01-28 財団法人化学及血清療法研究所 百日咳毒素のトキソイド化法
AU646019B2 (en) * 1990-02-12 1994-02-03 Smithkline Beecham Biologicals (Sa) Novel vaccine and method therefor

Also Published As

Publication number Publication date
ATE199059T1 (de) 2001-02-15
JPH07509481A (ja) 1995-10-19
EP0652771B2 (en) 2010-07-14
GB9216351D0 (en) 1992-09-16
GR3035683T3 (en) 2001-06-29
DE69329922T3 (de) 2010-12-09
DK0652771T4 (da) 2010-10-25
EP0652771A1 (en) 1995-05-17
CA2141410C (en) 2006-10-31
WO1994003206A1 (en) 1994-02-17
AU690518B2 (en) 1998-04-30
DE69329922T2 (de) 2001-05-23
AU4082693A (en) 1994-03-03
DE69329922D1 (de) 2001-03-15
CA2141410A1 (en) 1994-02-17
US6060067A (en) 2000-05-09
PT652771E (pt) 2001-05-31
EP0652771B1 (en) 2001-02-07
NZ252253A (en) 1996-10-28
ES2157219T5 (es) 2010-10-26
DK0652771T3 (da) 2001-02-26
JP3901212B2 (ja) 2007-04-04

Similar Documents

Publication Publication Date Title
ES2119812T3 (es) Catalasa, su produccion y uso.
FI960977A (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
ATE243735T1 (de) Alkalische lipase
SE9300140D0 (sv) Solid substrate
ES2157219T3 (es) Procedimiento de produccion de una vacuna antitetanica.
ATE157988T1 (de) Neuartige prolyl-endopeptidase-inhibitoren sna- 115 und sna-115t, ihre herstellung, und hierbei verwendete stämme
NO951750D0 (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
DK0631631T3 (da) Fremgangsmåde til fremstilling af hemproteiner
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
AU673344B2 (en) Vaccines based on streptokinase
AU7295891A (en) Novel heat-resistant beta-galactosyltransferase, its production process and its use
IE32044B1 (en) Process for the manufacture of a tetanus-vaccine
RU94003337A (ru) Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина
ATE223437T1 (de) Verwendung eines immunglobulinpräparates zur herstellung eines oral anzuwendenden medikaments zur prävention des hämolytischen urämischen syndroms sowie präparat hierfür
ES2141258T3 (es) Enzima y su uso en la preparacion de acido (s)-pipecolico.
SE9403636D0 (sv) Vaccine preparation
JPS572684A (en) Preparation of amylase inhibitor ai-b
ITMI913375A1 (it) Procedimento per la produzione di neuraminidasi
RU94003328A (ru) Штамм бактерий proteus mirabilis - продуцент термолабильного энтеротоксина
AU2318097A (en) Methods for detecting antibodies to hav 3c proteinase
SE8704922L (sv) Forfarande for framstellning av l-valin
MX9706609A (es) Procedimiento para la obtencion de aminas opticamente activas.
TH4461EX (th) การเตรียมเอนไซม์อีลาสเทส i จากตับอ่อนของคน

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 652771

Country of ref document: ES